Companies Dominating the Varicose Vein Treatment Landscape
- Candela Medical
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Medtronic PLC
- Boston Scientific
- El. En SpA Group
- Teleflex Incorporated
- Eufoton SRL
- Biolitec AG (BioMed Technology Holdings Ltd)
- AngioDynamics Inc.
- Alma Lasers Ltd
- Sciton Inc.
Browse Key Market Insights with Data Illustration:
In the News
- Medtronic has initiated an Investigation Device Exemption study for the assessment of the efficacy and safety of the Abre Venous Self-expanding Stent System intended to treat Deep Lymphocytic Diseases in order to establish its effectiveness and safety. It is likely that this study will be conducted at 35 locations across the United States and Europe, involving about 200 subjects.
- IVASC, an Italian medical device company, completed a EUR 1.8 million Series A investment in April 2022 for the launch of its VELEX product. VELEX, which received CE Mark in May 2021, is a device that can be used to treat CVI and varicose veins with a procedure called Empty Vein Ablation (EVA).
